NCT01044498 A Study of Tocilizumab in Combination With an Oral Contraceptive in Patients With Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01044017 A Study of Single Doses of RO4998452 in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01043484 Safety and Efficacy Study to Compare Capecitabine + Bevacizumab Versus Capecitabine, Concomitantly With Radiotherapy as Neoadjuvant Treatment for Patients With Localized and Resectable Rectal Cancer Status COMPLETED Phase PHASE2
NCT01043029 A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment Status COMPLETED Phase PHASE2
NCT01042769 A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE3
NCT01041404 ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE3
NCT01034397 A Study of Tocilizumab Plus Non-biological DMARD in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Non-biological DMARDs Status COMPLETED Phase PHASE4
NCT01034137 A Study of Tocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid Arthritis Status COMPLETED Phase PHASE3
NCT01033864 A Pharmacokinetic Study of CellCept (Mycophenolate Mofetil) Versus Mycophenolate Sodium in Kidney Transplant Patients Status COMPLETED Phase PHASE4
NCT01033734 A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza Status COMPLETED Phase PHASE1
NCT01033448 A Study of Extended Therapy of PEGASYS (Peginterferon Alfa-2a) in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C and Slow Response Status COMPLETED Phase PHASE4
NCT01032837 A Study of Tamiflu (Oseltamivir) for Treatment of Influenza With a Focus on (H1N1) 2009 Flu Strain Status TERMINATED Phase PHASE4
NCT01026142 A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA) Status COMPLETED Phase PHASE3
NCT01022918 Evaluation of the Irinotecan/Bevacizumab Association for Naive Unresectable Glioblastoma Status COMPLETED Phase PHASE2
NCT01022346 A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection Status COMPLETED Phase PHASE2
NCT01022086 Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab Status UNKNOWN Phase N/A
NCT01020175 Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation Status COMPLETED Phase PHASE3
NCT01018173 A Study of Taspoglutide in Patients With Inadequately Controlled Diabetes Mellitus Type 2 and Cardiovascular Disease Status COMPLETED Phase PHASE3
NCT01017302 A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy. Status COMPLETED Phase PHASE1
NCT01015625 Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer Status COMPLETED Phase NA